Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety

Fig. 2

Melittin nano-liposomes showed reduced toxicity in vivo. a Photos of the tails of each group at the end point of treatment. These mice were from the LM-3 model. b TUNEL assay for detecting apoptosis in the liver tissue after mice (n = 10) were treated with vehicle, blank liposomes (8 mg/kg), melittin (2 mg/kg), and melittin nano-liposomes (2 mg/kg) for 2 weeks. c Peripheral blood was collected from the ICR mice and analyzed by automated hematology analyzer

Back to article page